Silver nanoparticles induce anti-proliferative effects on airway smooth muscle cells. Role of nitric oxide and muscarinic receptor signaling pathway

Toxicology Letters

Volumn 224, Issue 2, 2014, Pages 246-256

  Ramírez Lee, Manuel A ^a   Rosas Hernández, Héctor ^a,c   Salazar García, Samuel ^a   Gutiérrez Hernández, José Manuel ^a   Espinosa Tanguma, Ricardo ^b   González, Francisco J ^a   Ali, Syed F ^c   González, Carmen ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Airway; Apoptosis; Muscarinic receptor; Nitric oxide; Proliferation; Silver nanoparticles

Indexed keywords

ACETYLCHOLINE; ATROPINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MUSCARINIC RECEPTOR; NITRIC OXIDE; SILVER NANOPARTICLE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER;

AIRWAY; APOPTOSIS; MUSCARINIC RECEPTOR; NITRIC OXIDE; PROLIFERATION; SILVER NANOPARTICLES;

ACETYLCHOLINE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; MALE; METAL NANOPARTICLES; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; SILVER; TRACHEA;

EID: 84888406607     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.10.027     Document Type: Article

References (77)

1. An S.S., Laudadio R.E., Lai J., et al. Stiffness changes in cultured airway smooth muscle cells. Am. J. Physiol. Cell Physiol. 2002, 283:C792-C801.
2. Antošová M., Strapková A., Nosál'ová G., et al. Effect of nitric oxide synthases inhibitors on exogenous irritant-induced bronchial hyper-reactivity in guinea pigs. Gen. Physiol. Biophys. 2006, 25(2):137-147.
3. AshaRani P.V., Kah Mun G.L., Prakash Hande M., et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3(2):279-290.
4. AshaRani P.V., Prakash Hande M., Valiyaveettil S., et al. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009, 10:65.
5. Barnes P.J., Dweik R.A., Gelb A.F., et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010, 138:682-692.
6. Benn T., Cavanagh T., Hristovski K., et al. The release of nanosilver from consumer products used in the home. J. Environ. Qual. 2010, 39:1875-1882.
7. Bezemer G., Bauer S.M., Oberdörster G., et al. Activation of pulmonary dendritic dells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. J. Innate Immunol. 2011, 3:150L 166.
8. Boncoeur E., Bouvet G., Migneault F., et al. Induction of nitric oxide synthase expression by lipopolysaccharide is mediated by calcium-dependent PKCα-β1 in alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013, 305(2):L175-L184.
9. Boop S.K., Lettieri T. Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line. BMC Pharmacol. 2008, 8:8-19.
10. British Standards Institution (BSI) Terminolog y for Nanomaterials 2007, (Publicly Available Specification 136).
11. Bryan N.S., Grisham M.B. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic. Biol. Med. 2007, 43(5):645-657.
12. Budd D.C., McDonald J., Emsley N., et al. The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties. J. Biol. Chem. 2003, 278(May (21)):19565-19573.
13. Bystrzejewska-Piotrowska G., Golimowski J., Urban P.L. Nanoparticles: their potential toxicity, waste and environmental management. Waste Manage. 2009, 29:2587-2595.
14. Capettini L.S.A., Cortes S.F., Lemos V.S. Relative contribution of eNOS and nNOS to endothelium-dependent vasodilation in the mouse aorta. Eur. J. Pharmacol. 2010, 643:260-266.
15. Card J.W., Zeldin D.C., Bonner J.C., et al. Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L400-L411.
16. Chaloupka K., Malam Y., Seifalian A.M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010, 28(11):580-588.
17. Chaturvedi R., de Sablet T., Coburn L.A., et al. Arginine and polyamines in helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids 2012, 42(2/3):627-640.
18. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 2008, 176(1):1-12.
19. De Boo S., Kopecka J., Brusa D., et al. iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells. Mol. Cancer 2009, 8:108.
20. Dekkers B.G.J., Bos I.S.T., Zaagsma J., et al. Functional consequences of human airway smooth muscle phenotype plasticity. Br. J. Pharmacol. 2012, 166:359-367.
21. Erdely A., Hulderman T., Salmen R., et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 2008, 9(1):36-43.
22. Español A.J., Goren N., Ribeiro M.L., et al. Nitric oxide synthase I and cyclooxigenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells. Inflamm. Res. 2010, 59(3):227-238.
23. Feng X., Sun T., Bei Y., et al. S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis. Sci. Rep. 2013, 3:1814.
24. Ferretti M., Fabbiano C., Di Bari M., et al. M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells. J. Cell. Mol. Med. 2013, 17(4):552-566.
25. Fiorino J.D. Voluntary Initiatives, Regulation, and Nanotechnology Oversight: Charting a Path, Project on Emerging Nanotechnologies 2010.
26. Foldbjerg R., Dang D.A., Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human cancer cell line, A549. Arch. Toxicol. 2011, 85(7):743-750.
27. Geiser M., Rothen-Rutishauser B., Kapp N., et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 2005, 113(11):1555-1560.
28. Gelb A.F., Barnes P.J., George S.C., et al. Review of exhaled nitric oxide in chronic obstructive pulmonary disease. J. Breath Res. 2012, 6(4):047101.
29. Genter M.B., Newman N.C., Shertzer H.G., et al. Distribution and systemic effects of intranasally administered 25nm silver nanoparticles in adult mice. Toxicol. Pathol. 2012, 40:1004-1013.
30. Ghosh S., Erzurum S.C. Nitric oxide metabolism in asthma pathophysiology. Biochim. Biophys. Acta 2011, 1810(November (11)):1008-1016.
31. González G., Salazar-García S., Palestino G., et al. Effect of 45nm silver nanoparticles (AgNPs) upon the smooth muscle of rat trachea: role of nitric oxide. Toxicol. Lett. 2011, 207(3):306-313.
32. Gosens R., Nelemans S.A., Grootte-Bromhaar M.M., et al. Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am. J. Respir. Cell. Mol. Biol. 2003, 28:257-262.
33. Gosens R., Zaagsma J., Bromhaar M.G., et al. Acetylcholine: a novel regulator of airway smooth muscle remodelling?. Eur. J. Pharmacol. 2004, 500:193-201.
34. Gosens R., Zaagsma J., Meurs H., et al. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res. 2006, 7:73.
35. Gougoura S., Liakos P., Koukoulis G.N. Effect of CRH on NO bioavailability, ROS production and antioxidant defense systems in endothelial EAhy926 cells. Free Radic. Res. 2010, 44(7):803-812.
36. Hamad A.M., Johnson S.R., Knox A.J. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 1999, 277:L910-L918.
37. Hamad A.M., Knox A.J. Mechanisms mediating the antiproliferative effects of nitric oxide in cultured human airway smooth muscle cells. FEBS Lett. 2001, 506:91-96.
38. Hirano T., Matsunaga K., Sugiura H., et al. Persistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthma. Respir. Investig. 2013, 51:84-91.
39. Hui Y., Zhao Y., Ma N., et al. M3-mAChR stimulation exerts anti-apoptotic effect via activating the HIF-1α/HO-1/VEGF signaling pathway in H9c2 rat ventricular cells. J. Cardiovasc. Pharmacol. 2012, 60(5):474-482.
40. Ito K., Caramori G., Adcock I.M. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J. Pharmacol. Exp. Ther. 2007, 321:1-8.
41. Ji J.H., Jung J.H., Kim S.S., et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2007, 19(10):857-871.
42. Karakiulakis G., Roth M. Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects. Mediators Inflamm. 2012, 2012:409580.
43. Kim H.R., Kim M.J., Lee S.Y., et al. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat. Res. 2011, 726:129-135.
44. Kim T.H., Kim M., Park H.S., et al. Size-dependent cellular toxicity of silver nanoparticles. J. Biomed. Mater. Res. 2011, 100(4):1033-1043.
45. Kistemaker L.E., Oenema T.A., Meurs H., et al. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sci. 2012, 91(21/22):1126-1133.
46. Kolahian S., Gosens R. Cholinergic regulation of airway inflammation and remodelling. J. Allergy (Cairo) 2012, 2012:681258.
47. Krymskaya V.P. Targeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle: rationale and promise. BioDrugs 2007, 21(2):85-95.
48. 2+ channels and Rho kinase. Scand. J. Gastroenterol. 2013, 48(2):205-212.
49. Lips K.S., Lührmann A., Tschernig T., et al. Down-regulation of the non-neuronal acetylcholine synthesis and release machinery in acute allergic airway inflammation of rat and mouse. Life Sci. 2007, 80(24/25):2263-2269.
50. Marques R.H., Reis F.G., Starling C.M., et al. Inducible nitric oxide synthase inhibition attenuates physical stress-induced lung hyper-responsiveness and oxidative stress in animals with lung inflammation. Neuroimmunomodulation 2012, 19(3):158-170.
51. Martínez-Castañón G.A., Niño-Martínez N., Martínez-Gutierrez F., et al. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J. Nanopart. Res. 2008, 10:1343-1348.
52. 2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells. Br. J. Pharmacol. 1998, 125:1768-1778.
53. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Biol. Chem. 2001, 5(1):62-71.
54. Morones J.R., Elechiguerra J.L., Camacho A., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
55. Murdock R.C., Braydich-Stolle L., Schrand A.M., et al. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol. Sci. 2008, 101:239-253.
56. Pascual R.M., Peters S.P. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J. Allergy Clin. Immunol. 2005, 116(3):477-486.
57. Poda A.R., Bednar A.J., Kennedy A.J., et al. Characterization of silver nanoparticles using flow-field flow fractionation interfaced to inductively coupled plasma mass spectrometry. J. Chromatogr. A 2011, 1218(27):4219-4225.
58. Quadros M.E., Marr L.C. Environmental and human health risks of aerosolized silver nanoparticles. J. Air Waste Manage. Assoc. 2010, 60:770-781.
59. Ravichandran K., Tyagi A., Deep G., et al. Interleukin-1b-induced iNOS expression in human lung carcinoma A549 cells: involvement of STAT and MAPK pathways. Ind. J. Exp. Biol. 2011, 49:840-847.
60. Rejeski D. An inventory of nanotechnology-based consumer products currently on the market; Project on Emerging Nanotechnologies 2013, available at http://www.nanotechproject.org/inventories/consumer (accessed March 2013).
61. Ricciardolo F.L.M., Sterk P.J., Gaston B., et al. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004, 84(3):731-765.
62. Roth M. Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?. J. Allergy (Cairo) 2011, 2011:721517.
63. Rus A., Peinado M.A., Castro L., et al. Lung eNOS and iNOS are reoxygenationtime-dependent upregulated after acute hypoxia. Anat. Rec. 2010, 293:1089-1098.
64. Shi Q., Wang X., Yu W., et al. Influence of the concentration of silver nanoparticles on the proliferation behavior of human umbilical vein endothelial cell and human umbilical artery smooth muscle cells. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2010, 27(4):875-881.
65. Suresh A.K., Pelletier D.A., Wang W., et al. Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir 2012, 28:2727-2735.
66. Stoehr L.C., Gonzalez E., Stampfl A., et al. Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part. Fibre Toxicol. 2011, 8:36.
67. Sugiura H., Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide 2011, 25:138-144.
68. Sung J.H., Ji J.H., Park J.D., et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 2009, 108(2):452-461.
69. Sung J.H., Ji J.H., Song K.S., et al. Acute inhalation toxicity of silver nanoparticles. Toxicol. Ind. Health 2011, 27(2):149-154.
70. Sung J.H., Ji J.H., Yoon J.U., et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 2008, 20(6):567-574.
71. Takahashi K., Sugiyama T., Tokoro S., et al. Inhibitory effect of 10-hydroxydecanoic acid on lipopolysaccharide-induced nitric oxide production via translational downregulation of interferon regulatory factor-1 in RAW264 murine macrophages. Biomed. Res. 2013, 34(4):205-214.
72. Wright D.B., Trian T., Siddiqui S., et al. Phenotype modulation of airway smooth muscle in asthma. Pulm. Pharmacol. Therap. 2013, 26:42-49.
73. Xia X., Hu X., Wu L., et al. Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats. Mol. Cell. Biochem. 2012, 359:293-299.
74. Xiong Y., Yu Y., Montani J.P., et al. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J. Am. Heart Assoc. 2013, 2(4):e000096.
75. Yang P., Han Y., Gui L., et al. Gastrodin attenuation of the inflammatory response in H9c2 cardiomyocytes involves inhibition of NF-κB and MAPKs activation via the phosphatidylinositol 3-kinase signaling. Biochem. Pharmacol. 2013, 85(8):1124-1133.
76. Zhou L., Zhu D.A. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009, 20:223-230.
77. Zuckerbraun B.S., Stoyanovsky D.A., Sengupta R., et al. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am. J. Physiol. Cell Physiol. 2007, 292:C824-C831.